title: Myofibroblast induction with transforming growth factor-beta1 and -beta3 in cutaneous fetal excisional wounds.
abstract: OBJECTIVE
  In a noncontractile fetal rabbit model, the authors recently have shown the induction of excisional wound contraction with sustained-release cellulose implants formulated with transforming growth factor (TGF)-beta. The purpose of this study was to test the hypothesis that the excisional wound contraction in this model is associated with the induction of myofibroblasts in the surrounding dermis, demonstrated by the presence of alpha-smooth muscle actin.
  
  
  METHODS
  Cellulose discs were formulated with either 1.0 microg of TGF-beta1 (n = 6); 1.0 microg of TGF-beta3 (n = 9); 10 microg of TGF-beta3 (n = 6); or their carrier protein, bovine serum albumin (BSA; n = 9), for sustained-release over 5 days. Each disc was implanted into a subcutaneous pocket on the back of a fetal New Zealand White rabbit in utero on day 24 of gestation (term, 31 days). A full-thickness, 3-mm excisional wound (7.4 mm2) was then made next to the implanted cellulose disc. All fetuses were harvested at 3 days. The amount of alpha-smooth muscle (SM) actin in the dermis around the implants and wounds was determined using immunohistochemical techniques.
  
  
  RESULTS
  Excisional wounds exposed to 1.0 microg of TGF-beta1 (5.6+/-2.0 mm2), 1.0 microg of TGF-beta3 (6.9+/-1.0 mm2), and 10 microg of TGF-beta3 (2.7+/-1.0 mm2) were significantly smaller when compared with the BSA control group (12.8+/-1.1 mm2; P<.05). Furthermore, there was a significant increase in staining for alpha-SM actin in the TGF-beta1 (1.8+/-0.5) and 10 microg TGF-beta3 (2.8+/-0.2) groups in comparison with the scant staining in the BSA control group (0.5+/-0.2; P<.05).
  
  
  CONCLUSIONS
  TGF-beta1 and -beta3 induce alpha-SM actin and contraction of cutaneous excisional wounds in a fetal noncontractile model. This model of inducible cutaneous excisional wound contraction may be useful in further determining the role of the myofibroblast in wound contraction and the physiology underlying this poorly understood aspect of wound healing.
authors.affiliation: Department of Surgery, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Lanning
authors.forename: R F
authors.initials: RF
authors.lastname: Diegelmann
authors.forename: D R
authors.initials: DR
authors.lastname: Yager
authors.forename: M L
authors.initials: ML
authors.lastname: Wallace
authors.forename: C E
authors.initials: CE
authors.lastname: Bagwell
authors.forename: J H
authors.initials: JH
authors.lastname: Haynes
mesh_terms: D000199:Actins / Q000032:analysis*; D000818:Animals; D020405:Dermis / Q000737:chemistry* / Q000502:physiology*; D005333:Fetus / Q000601:surgery*; D005347:Fibroblasts / Q000502:physiology*; D007150:Immunohistochemistry; D011817:Rabbits; D016211:Transforming Growth Factor alpha / Q000502:physiology*; D016212:Transforming Growth Factor beta / Q000502:physiology*; D014945:Wound Healing / Q000502:physiology*
chemical_list: D000199:Actins; D016211:Transforming Growth Factor alpha; D016212:Transforming Growth Factor beta